Target intelligence / Profile preview

Immune cell membranes and lysosomal compartments

Molecular classification
Cellular compartment, Organelle, Other
01

Overview

Immune cell membranes and lysosomal compartments refer to the structural organelles and lipid bilayers within leukocytes that facilitate essential immune processes such as antigen presentation and signal transduction (Schrezenmeier & Dörner, 2020). These compartments are characterized by an acidic internal environment maintained by V-ATPase proton pumps, which is crucial for the activity of various hydrolases and the maturation of endosomes (Ohkuma & Poole, 1978). In the context of pharmacology, these structures are the primary site of accumulation for lysosomotropic drugs like hydroxychloroquine, which partition into the membranes and concentrate within the lysosomal lumen (Kuznik et al., 2011). This accumulation raises the intra-lysosomal pH, thereby inhibiting the proteolytic processing of autoantigens and the activation of endosomal Toll-like receptors (TLRs) such as TLR7 and TLR9 (Wallace et al., 2012). Consequently, the disruption of these compartments modulates the inflammatory response in autoimmune diseases like systemic lupus erythematosus and rheumatoid arthritis (Mauthe et al., 2018). However, because this term describes a collection of cellular structures rather than a specific protein or enzyme, it is classified as a cellular location rather than a discrete molecular target.

Other names
Endolysosomal systemLysosomal compartmentAcidic vesiclesLeukocyte membranes
02

Mechanism of action

Lysosomotropic accumulation within acidic compartments leads to an increase in intralysosomal pH, which inhibits acid-dependent hydrolases (such as cathepsins) and interferes with the processing and signaling of endosomal Toll-like receptors (TLR7 and TLR9) (Schrezenmeier & Dörner, 2020; Kuznik et al., 2011).

03

Biological functions

Antigen processingAutophagyPhagocytosisToll-like receptor signalingEndocytosis
04

Disease associations

Systemic lupus erythematosusRheumatoid arthritisViral infectionMalariaSjogren's syndrome
05

Safety considerations

Retinal toxicity (retinopathy)QT interval prolongationNeuromuscular toxicityLysosomal storage-like myopathy
06

Interacting drugs

Hydroxychloroquine

3 more in the full profile.

07

Biomarkers

Lysosomal pHCathepsin B activityCathepsin L activityInterferon-alpha levels

Beyond the preview

Go deeper on Immune cell membranes and lysosomal compartments.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cell membranes and lysosomal compartments.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call